These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7800969)

  • 1. Stimulation of immunoprotective mechanisms by OM-85 BV. A review of results from in vivo and in vitro studies.
    Mauël J
    Respiration; 1994; 61 Suppl 1():8-15. PubMed ID: 7800969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th1-orientated immunological properties of the bacterial extract OM-85-BV.
    Huber M; Mossmann H; Bessler WG
    Eur J Med Res; 2005 May; 10(5):209-17. PubMed ID: 15946922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo study on the immunomodulating effects of OM-85 BV on survival, inflammatory cell recruitment and bacterial clearance in Klebsiella pneumonia.
    Broug-Holub E; Kraal G
    Int J Immunopharmacol; 1997; 19(9-10):559-64. PubMed ID: 9637354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage activation by OM-85 BV.
    Mauël J
    Respiration; 1992; 59 Suppl 3():14-8. PubMed ID: 1332156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OM-85 BV upregulates the expression of adhesion molecules on phagocytes through a CD 14-independent pathway.
    Marchant A; Goldman M
    Int J Immunopharmacol; 1996 Apr; 18(4):259-62. PubMed ID: 8894805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bacterial extract OM-85 BV protects mice against influenza and Salmonella infection.
    Bessler WG; Vor dem Esche U; Masihi N
    Int Immunopharmacol; 2010 Sep; 10(9):1086-90. PubMed ID: 20601184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with OM-85 BV in upper and lower respiratory tract infections.
    Derenne JP; Delclaux B
    Respiration; 1992; 59 Suppl 3():28-31. PubMed ID: 1439237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of interleukin 6 and interleukin 8 expression by Broncho-Vaxom (OM-85 BV) via C-Fos/serum responsive element.
    Keul R; Roth M; Papakonstantinou E; Nauck M; Perruchoud AP; Block LH
    Thorax; 1996 Feb; 51(2):150-4. PubMed ID: 8711646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of natural killer cells and cytokine production in man by bacterial extracts.
    Wybran J; Libin M; Schandene L
    Immunopharmacol Immunotoxicol; 1989; 11(1):17-32. PubMed ID: 2503554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bacterial extract of OM-85 Broncho-Vaxom prevents allergic rhinitis in mice.
    Han L; Zheng CP; Sun YQ; Xu G; Wen W; Fu QL
    Am J Rhinol Allergy; 2014; 28(2):110-6. PubMed ID: 24717947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy with an oral bacterial extract (OM-85 BV) for upper respiratory infections.
    Paupe J
    Respiration; 1991; 58(3-4):150-4. PubMed ID: 1745846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of OM-85 BV in children suffering from recurrent respiratory tract infections and subnormal IgG subclass levels.
    Del-Río-Navarro BE; Luis Sienra-Monge JJ; Berber A; Torres-Alcántara S; Avila-Castañón L; Gómez-Barreto D
    Allergol Immunopathol (Madr); 2003; 31(1):7-13. PubMed ID: 12573204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation by a bacterial extract (Broncho-Vaxom) of the metabolic and functional activities of murine macrophages.
    Mauel J; Van Pham T; Kreis B; Bauer J
    Int J Immunopharmacol; 1989; 11(6):637-45. PubMed ID: 2553625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of OM-85 BV on different humoral and cellular immune defense mechanisms of the respiratory tract.
    Emmerich B; Pachmann K; Milatovic D; Emslander HP
    Respiration; 1992; 59 Suppl 3():19-23. PubMed ID: 1439235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of natural killer cells and cytokine production in humans by bacterial extracts (OM-85 BV).
    Wybran J; Libin M; Schandene L
    Lung; 1990; 168 Suppl():720-5. PubMed ID: 2117183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of OM-85 BV on hBD-1 and immunoglobulin in children with asthma and recurrent respiratory tract infection].
    Liao JY; Zhang T
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 May; 16(5):508-12. PubMed ID: 24857002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial immunostimulants--mechanism of action and clinical application in respiratory diseases.
    Rozy A; Chorostowska-Wynimko J
    Pneumonol Alergol Pol; 2008; 76(5):353-9. PubMed ID: 19003766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a mixed bacterial lysate (OM-85 BV) on the immunogenicity, safety and tolerability of inactivated influenza vaccine in children with recurrent respiratory tract infection.
    Esposito S; Marchisio P; Prada E; Daleno C; Porretti L; Carsetti R; Bosco A; Ierardi V; Scala A; Principi N
    Vaccine; 2014 May; 32(22):2546-52. PubMed ID: 24681270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of two courses of OM-85 BV in the prevention of respiratory tract infections in children during 12 months.
    Gutiérrez-Tarango MD; Berber A
    Chest; 2001 Jun; 119(6):1742-8. PubMed ID: 11399700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial lysate increases the percentage of natural killer T cells in peripheral blood and alleviates asthma in children.
    Lu Y; Li Y; Xu L; Xia M; Cao L
    Pharmacology; 2015; 95(3-4):139-44. PubMed ID: 25833066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.